Parexel
Mandakini Singh, Ph.D., is a skilled scientific writer at Parexel since July 2022, specializing in high-quality scientific content development across various disease states, including clinical neurosciences and oncology. Prior to this role, Mandakini worked as a medical and scientific writer at Chameleon Communications International and as a postdoctoral scholar and guest lecturer at the University of Connecticut, focusing on molecular mechanisms related to substance use disorder and safety pharmacology. With a solid background in research, including postdoctoral fellowships at UConn Health and the Indian Institute of Technology, Bombay, Mandakini holds a Ph.D. in Biomedical Sciences (Neuroscience) from The University of Connecticut Health Center and advanced degrees in Biochemistry and a Bachelor's in Physics, Mathematics, and Chemistry.
This person is not in any teams
This person is not in any offices
Parexel
13 followers
Parexel is focused on the development of innovative new therapies to improve the world’s health.